日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma

Pelabresib (CPI-0610)(一种 BET 蛋白的小分子抑制剂)在复发或难治性淋巴瘤患者中的 I 期研究

Kristie A Blum, Jeffrey G Supko, Michael B Maris, Ian W Flinn, Andre Goy, Anas Younes, Suresh Bobba, Adrian M Senderowicz, Sergey Efuni, Ronda Rippley, Gozde Colak, Patrick Trojer, Jeremy S Abramson

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis

基于群体药代动力学分析的晚期恶性肿瘤患者西米普利单抗固定剂量治疗

Paccaly, Anne J; Migden, Michael R; Papadopoulos, Kyriakos P; Yang, Feng; Davis, John D; Rippley, Ronda K; Lowy, Israel; Fury, Matthew G; Stankevich, Elizabeth; Rischin, Danny

Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid Arthritis

中性粒细胞边缘化和耐受性的群体药效学模型用于描述沙利鲁单抗对类风湿关节炎患者绝对中性粒细胞计数的影响

Kovalenko, Pavel; Paccaly, Anne; Boyapati, Anita; Xu, Christine; St John, Gregory; Nivens, Michael C; Davis, John D; Rippley, Ronda; DiCioccio, A Thomas

The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects

健康成年受试者单次口服和静脉注射替卡泮后的剂量比例性

Han, Tae H; Blanchard, Rebecca L; Palcza, John; Martucci, Ashley; Miller-Stein, Cynthia M; Gutierrez, Maria; Panebianco, Deborah; Rippley, Ronda K; Lines, Christopher; Murphy, M Gail

Effects of cellular pharmacology on drug distribution in tissues

细胞药理学对药物在组织中分布的影响

Rippley, R K; Stokes, C L